Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

ClinicalTrials.gov ID: NCT07837973

Public ClinicalTrials.gov record NCT07837973. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 11, 2026, 3:46 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Multi-Center, Dose-Ranging, Phase 2 Study of the Efficacy and Safety of ALV-100 Versus Placebo for Maintenance of Weight Loss in Patients Previously Treated With Incretin-Based Therapies

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A study of ALV-100 to assess efficacy, safety and tolerability among participants with overweight or obesity who have previously achieved a body weight reduction of ≥10% while treated with incretin-based therapies.

Study identification

NCT ID: NCT07837973
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Alveus Therapeutics, Inc.; Industry
Enrollment: 220 participants

Conditions and interventions

Conditions

Interventions

ALV-100 Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 75 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 10, 2026 (Actual)
Primary completion: Aug 24, 2027 (Estimated)
Completion: Aug 24, 2027 (Estimated)
Last update posted: Oct 26, 2026

2026 – 2027

United States locations

U.S. sites: 20
U.S. states: 14
U.S. cities: 19

Facility	City	State	ZIP	Site status
University of Alabama - Birmingham	Birmingham	Alabama	35294	Recruiting
DM Clinical Research	Sun City	Arizona	85373	Recruiting
AMR Clinical	Tempe	Arizona	85281	Recruiting
Profound Research	Oceanside	California	92058	Recruiting
DM Clinical Research	Bradenton	Florida	34209	Recruiting
DM Clinical Research	Doral	Florida	33166	Recruiting
Clinical Neuroscience Solutions	Orlando	Florida	32801	Recruiting
North Georgia Clinical Research	Woodstock	Georgia	30189	Recruiting
Christie Clinic	Champaign	Illinois	61822	Recruiting
BRCR Global Louisiana	Gretna	Louisiana	70053	Recruiting
Profound Research	Farmington Hills	Michigan	48334	Recruiting
ALSA Research-Manhattan	New York	New York	10016	Recruiting
TMA Headlands	Wilmington	North Carolina	28403	Recruiting
Lynn Health Science Institute	Oklahoma City	Oklahoma	73106	Recruiting
AMR Clinical	Nashville	Tennessee	37203	Recruiting
DM Clinical Research	Irving	Texas	75063	Recruiting
DM Clinical Research - Dominion Family Healthcare	San Antonio	Texas	78257	Recruiting
Tekton Research	San Antonio	Texas	78258	Recruiting
DM Clinical Research	Tomball	Texas	77375	Recruiting
AMR Clinical	South Jordan	Utah	84095	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07837973, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 26, 2026 · Synced Nov 11, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07837973 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →